Cal Solar Inc. Launches CA-Wide Solar EPC Services Division with In-House Engineering & Installation
LOS ANGELES–(BUSINESS WIRE)–Cal Solar Inc. has announced a formal launch of its EPC services (meaning…
Year: 2022
Boehringer Ingelheim signs Option to Acquire Trutino Biosciences
INGELHEIM, Germany & SAN DIEGO–(BUSINESS WIRE)–Boehringer Ingelheim today announced the signing of an option to…
Industrial Printer Shipments Show Modest Decrease in Q1 2022, According to IDC
NEEDHAM, Mass.–(BUSINESS WIRE)–#DirecttoGarmentPrinter–Industrial printer shipments declined 2.1% year over year in the first quarter of…
Discovered Intelligence Launches Aura Asset Intelligence 3.0, greatly advancing asset discovery and endpoint compliance capabilities
TORONTO, June 14, 2022 (GLOBE NEWSWIRE) — Discovered Intelligence Inc. An award winning Splunk® services…
Qualigen Therapeutics to Present at BIO International Convention
Qualigen Therapeutics, Inc. Tariq Arshad CARLSBAD, Calif., June 14, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics,…
Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer
Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize…
Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
CAMBRIDGE, Mass., June 14, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Pike Therapeutics Announces Positive Pharmacokinetic Animal Study Results and Unexpected Benefits for its Proprietary Weekly CBD Continuous Transdermal Delivery Technology
HIGHLIGHTS: – Positive 7-day continuous delivery of CBD in rabbits equivalent to 35 mg/kg/day oral…
Healthy Extracts CEO Discusses Health and Wellness on Here’s To Your Health With Joshua Lane
LAS VEGAS, June 14, 2022 (GLOBE NEWSWIRE) — Duke Pitts, CEO of Healthy Extracts Inc….
Pharvaris Announces Annual Meeting of Shareholders
ZUG, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing…
Outlook Therapeutics Confirms Status of Biologics License Application (BLA) Submission for ONS-5010
Outlook Therapeutics reiterates expected re-submission of BLA by September 2022 following receipt of additional correspondence…
Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing Facility
AD/PD Laboratories Open Exactly Eight Months After Announced Plans to Build Viral Vector Facility Build-Out…
Tilray Brands Announces Enhancements to Accretive Strategic Transaction with HEXO
Amended Terms Include Increased Discount on Purchase Price of HEXO Note and Reduced Tilray Conversion…
aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment
Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA…
Hepion Pharmaceuticals Appoints Accomplished Life Sciences Industry Veteran, Dr. Launa J. Aspeslet, as Chief Operating Officer
– Dr. Aspeslet joins the Company to support rencofilstat’s clinical program – EDISON, N.J., June…
Acasti Pharma Announces the Issuance of Additional Patents for GTX-104 and GTX-101
LAVAL, Québec, June 14, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions
VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections
YONKERS, N.Y., June 14, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage…
Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting Firm
FORT COLLINS, Colo., June 14, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Vyluma and Laboratoires Théa Enter into Licensing Agreement for the Registration and Commercialization of NVK002 in Canada, Mexico, and Select South American Countries
BRIDGEWATER, N.J., June 14, 2022 (GLOBE NEWSWIRE) — Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing…